{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-travel/management/poliomyelitis/","result":{"pageContext":{"chapter":{"id":"0e84be27-375b-55f5-9f51-d0e4cc422b58","slug":"poliomyelitis","fullItemName":"Scenario: Poliomyelitis","depth":2,"htmlHeader":"<!-- begin field f618076b-583e-40ed-8ce2-7e332005eb95 --><h2>Scenario: Poliomyelitis</h2><!-- end field f618076b-583e-40ed-8ce2-7e332005eb95 -->","summary":"Covers advice for people who are not immunized against poliomyelitis and are travelling to endemic areas.","htmlStringContent":"<!-- begin item ddbae6d6-d74b-417a-9235-4f077cd5cf77 --><!-- begin field 7fce7d74-445b-49b6-a612-acd900ab5245 --><p>From age 2 months onwards.</p><!-- end field 7fce7d74-445b-49b6-a612-acd900ab5245 --><!-- end item ddbae6d6-d74b-417a-9235-4f077cd5cf77 -->","topic":{"id":"8f89ca7f-a4f5-5e7d-80c8-de5db64ca7f0","topicId":"16d61716-d647-48bc-827b-b2b115ecd0fb","topicName":"Immunizations - travel","slug":"immunizations-travel","lastRevised":"Last revised in January 2021","chapters":[{"id":"25b90177-7e96-59db-b325-abc5f51c8721","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bc7c22b0-dd64-50ad-8110-1fff4c8d6736","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"50f55046-7ca2-567f-94df-9c58f13770a5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2221cdd9-5576-5b5b-ad29-eff077930653","slug":"changes","fullItemName":"Changes"},{"id":"c755b06c-072d-5e60-be73-155dd664c37d","slug":"update","fullItemName":"Update"}]},{"id":"f5871d9a-dff3-59ce-a611-88d2ec41f5ce","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"513a86a0-e305-5e59-bd0d-1fb74a6e8689","slug":"goals","fullItemName":"Goals"},{"id":"87ea4699-bd41-5aeb-aa62-eac1fb591c4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c8b054a0-ee87-5f9e-aa8f-c1fdf8442a29","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a8eb4582-f05d-5af5-ae78-497260724f93","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f29b0b8-4b10-5e26-9ece-4cec050b1eb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"79cb1d1a-ebd1-58c6-9bc5-2bfd006c22c1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8d3187f5-2a99-5108-a7c9-dd601d729381","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"055aad08-f5af-5b2f-bda0-a35213a2a071","slug":"travel-vaccinations","fullItemName":"Travel vaccinations"},{"id":"c8d1352b-616b-5dff-9517-ea235b83e9d9","slug":"diseases-commonly-requiring-vaccination","fullItemName":"Diseases commonly requiring vaccination"},{"id":"041fa115-033d-5525-91ce-c43dbf593bd4","slug":"other-diseases-requiring-vaccination","fullItemName":"Other diseases requiring vaccination"},{"id":"1fe14ee1-a79f-565a-9380-ae3be597d7d5","slug":"where-these-diseases-are-prevalent","fullItemName":"Where these diseases are prevalent"},{"id":"68e09f74-2282-532f-ae34-064998823fc1","slug":"payment-for-travel-vaccinations","fullItemName":"Payment for travel vaccinations"}]},{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c16c0cb-4e78-523d-914f-e884aea62565","slug":"initial-assessment-advice","fullItemName":"Scenario: Initial assessment and advice"},{"id":"f911dc04-ffd0-5a41-a3cb-b724797a7589","slug":"cholera","fullItemName":"Scenario: Cholera"},{"id":"422ff6d3-5810-5d3c-93b3-c5a67faaa0e1","slug":"hepatitis-a","fullItemName":"Scenario: Hepatitis A"},{"id":"01d49a70-70f4-547a-a551-ab524f99c944","slug":"hepatitis-b","fullItemName":"Scenario: Hepatitis B"},{"id":"5c77503c-2f59-5696-908b-125fe0e8e41c","slug":"japanese-encephalitis","fullItemName":"Scenario: Japanese encephalitis"},{"id":"8cb4ca86-fe31-5603-a75e-84413c2b5346","slug":"meningococcal-meningitis","fullItemName":"Scenario: Meningococcal meningitis"},{"id":"0e84be27-375b-55f5-9f51-d0e4cc422b58","slug":"poliomyelitis","fullItemName":"Scenario: Poliomyelitis"},{"id":"37a96f8b-4158-5e62-8e3d-6cedae506976","slug":"rabies","fullItemName":"Scenario: Rabies"},{"id":"8c237a0e-a760-55b2-b7b0-5383b7653be3","slug":"tetanus","fullItemName":"Scenario: Tetanus"},{"id":"85c90e1f-26f4-503b-b0b0-7c5a38930086","slug":"tick-borne-encephalitis","fullItemName":"Scenario: Tick-borne encephalitis"},{"id":"4e817d26-15f3-5ff7-a672-11caa36ffb68","slug":"typhoid-fever","fullItemName":"Scenario: Typhoid fever"},{"id":"5ec20606-2af2-556b-98a6-d8673a21a09d","slug":"yellow-fever","fullItemName":"Scenario: Yellow fever"},{"id":"e0a021ac-7c76-551a-97af-25341142d54f","slug":"hajj-umrah-pilgrims","fullItemName":"Scenario: Hajj and Umrah pilgrims"},{"id":"087d9fbb-1ec6-5f08-8e76-5df3a4a0b863","slug":"rapid-vaccination-courses-vaccination-at-short-notice","fullItemName":"Scenario: Rapid vaccination courses and vaccination at short notice"}]},{"id":"79dee816-dbdb-5426-8db3-2f095eedbff3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f1e9d43f-6815-516a-8511-3fd34a06525d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a69fb594-d4b4-56e6-b46a-6283ead93e30","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"52eea726-d50b-5e4f-a22c-764c1961119d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b2033c1b-25a2-5a58-b99e-00baf9b02a96","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6df4842b-8812-534e-975d-52d29f3a8ee4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81e42472-4b49-5390-8179-0d131f547700","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"86482706-09b2-5113-bd4e-261c392f6483","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"97eb0aea-8c3c-5ad3-9096-2b01c4313e62","slug":"indications-for-vaccine","fullItemName":"Indications for vaccine","depth":3,"htmlHeader":"<!-- begin field 7f8d9815-8c81-491c-8759-5fb9d746a0da --><h3>Indications for vaccine</h3><!-- end field 7f8d9815-8c81-491c-8759-5fb9d746a0da -->","summary":null,"htmlStringContent":"<!-- begin item 92df391f-d5d6-4c9e-b3a1-f12d597f8c16 --><!-- begin field e1142c98-70a8-4412-9204-7aeb7bb95718 --><ul><li>Vaccination is indicated for people who are travelling to areas or <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/background-information/where-these-diseases-are-prevalent/\">countries</a> where poliomyelitis (polio) is epidemic or endemic if:<ul><li>They have not been previously immunized.</li><li>They have not been fully immunized according to the UK schedule.</li><li>Their last dose of polio vaccine was 10 years ago, or more.</li></ul></li><li>Polio vaccination is part of the routine Childhood Immunization Programme in the UK. For more information see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-childhood/\">Immunizations - childhood</a>.</li></ul><!-- end field e1142c98-70a8-4412-9204-7aeb7bb95718 --><!-- end item 92df391f-d5d6-4c9e-b3a1-f12d597f8c16 -->","subChapters":[{"id":"1b37b1bf-a600-5633-a30c-8448c576906b","slug":"basis-for-recommendation-eed","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field baea5e8e-8edd-4673-9746-09c22a823c1c --><h4>Basis for recommendation</h4><!-- end field baea5e8e-8edd-4673-9746-09c22a823c1c -->","summary":null,"htmlStringContent":"<!-- begin item eed5a021-291d-4cf1-b8e6-b6a0f420c91a --><!-- begin field c7320b4b-a558-48e5-adb9-a337d5fa760b --><p>The recommendations on indications for polio vaccination are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 26: Poliomyelitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013b</a>].</p><!-- end field c7320b4b-a558-48e5-adb9-a337d5fa760b --><!-- end item eed5a021-291d-4cf1-b8e6-b6a0f420c91a -->","subChapters":[]}]},{"id":"0edd3b82-b2f2-50c9-b0c8-4d875de847df","slug":"available-vaccines-vaccination-schedules","fullItemName":"Available vaccines and vaccination schedules","depth":3,"htmlHeader":"<!-- begin field f35d279e-c96b-4561-8434-5dc824115eb2 --><h3>Available vaccines and vaccination schedules</h3><!-- end field f35d279e-c96b-4561-8434-5dc824115eb2 -->","summary":null,"htmlStringContent":"<!-- begin item 06e0a138-df6f-47dd-a802-84e52ad8b152 --><!-- begin field 443f3760-25e1-41af-a4b0-3998f5c7cef2 --><ul><li><strong>Polio vaccine is only available as part of a combined product, with choice of vaccine being largely dependent on the person's age and prior vaccination history. The available products in the UK are:</strong><ul><li>Boostrix IPV<sup>® </sup>(dTaP/IPV).</li><li>Infanrix Hexa<sup>® </sup>(dTaP/IPV/HBV/Hib).</li><li>Infanrix<sup>®</sup> (dTaP/IPV/Hib).</li><li>Repevax<sup>® </sup>(dTaP/IPV).</li><li>Revaxis<sup>® </sup>(Td/IPV).</li></ul></li><li><strong>Ensure that ALL people are up to date with the recommended five-dose schedule for polio immunization, regardless of travel arrangements.</strong><ul><li>Anyone born before 1962 may not have received polio vaccination or may have received a low potency vaccine.</li></ul></li><li><strong>For children under 10 years of age who have not been vaccinated </strong>—<strong> </strong>vaccinate according to the Routine Childhood Immunization Programme. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-childhood/\">Immunizations - childhood</a>.</li><li><strong>For children over 10 years of age and adults who have not been vaccinated </strong>—<strong> </strong>give a primary course of three doses of vaccine (as Td/IPV) 1 month apart, and two booster doses (the first at least 5 years after the last dose of the primary course, and the second 10 years after the first booster).</li><li><strong>For travellers to polio endemic or epidemic regions who have been vaccinated</strong> — give a booster dose if the person has not received one in the last 10 years.<ul><li>This is particularly important for health workers in endemic regions.</li></ul></li></ul><!-- end field 443f3760-25e1-41af-a4b0-3998f5c7cef2 --><!-- end item 06e0a138-df6f-47dd-a802-84e52ad8b152 -->","subChapters":[{"id":"ca67a2d7-e8b5-5816-a708-d4fc9c0b6f2d","slug":"basis-for-recommendation-fc0","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ff699de8-978b-4478-9a4e-29dc622dc971 --><h4>Basis for recommendation</h4><!-- end field ff699de8-978b-4478-9a4e-29dc622dc971 -->","summary":null,"htmlStringContent":"<!-- begin item fc027cee-5dab-4160-91a5-b51882aa1abc --><!-- begin field 7cce1b23-8049-4b45-9562-f39ae89c3389 --><p>The information on available types of polio vaccine and vaccination schedules is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 26: Poliomyelitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013b</a>] as well as product information from the manufacturers of the polio-containing vaccines available in the UK [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">ABPI, 2020d</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">ABPI, 2020e</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">ABPI, 2020f</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">ABPI, 2020g</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">ABPI, 2020h</a>].</p><!-- end field 7cce1b23-8049-4b45-9562-f39ae89c3389 --><!-- end item fc027cee-5dab-4160-91a5-b51882aa1abc -->","subChapters":[]}]},{"id":"f78ed6a1-b075-5473-884c-96ae1f452965","slug":"contraindications-to-vaccine","fullItemName":"Contraindications to vaccine","depth":3,"htmlHeader":"<!-- begin field 711b3f9c-39f5-49e9-ab62-ab99b789978c --><h3>Contraindications to vaccine</h3><!-- end field 711b3f9c-39f5-49e9-ab62-ab99b789978c -->","summary":null,"htmlStringContent":"<!-- begin item dcea7fcf-5aa0-4d8b-8469-4ef33196277b --><!-- begin field 11073f4d-069c-4846-a7d4-66d3732cd305 --><ul><li><strong>Polio vaccines should not be given to people who have had:</strong><ul><li>A confirmed anaphylactic reaction, or serious systemic reaction following a previous dose.</li><li>A confirmed anaphylactic reaction to neomycin, streptomycin, or polymyxin B (which may be present in trace amounts).</li></ul></li><li><strong>Postpone polio vaccination if the person has a current severe febrile illness.</strong><ul><li>Minor illness without fever or systemic upset is <em>not</em> a valid reason to postpone immunization.</li></ul></li><li><strong>Children should continue immunization with polio-containing vaccines </strong>even with a history of fever (irrespective of severity), hypotonic–hyporesponsive episodes (HHE), persistent crying or screaming for more than 3 hours, or a severe local reaction (irrespective of extent) within 72 hours of a previous polio vaccination. </li><li><strong>Polio-containing vaccines may be given to pregnant women when protection is required without delay.</strong> There is no evidence of risk from vaccinating pregnant women or those who are breastfeeding with inactivated virus, bacterial vaccines, or toxoids.</li></ul><!-- end field 11073f4d-069c-4846-a7d4-66d3732cd305 --><!-- end item dcea7fcf-5aa0-4d8b-8469-4ef33196277b -->","subChapters":[{"id":"eecb2b9b-7e5a-554d-8d1f-877329e38ca3","slug":"basis-for-recommendation-c9e","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 61ee7d68-9c1a-438f-af9d-48acf12bded5 --><h4>Basis for recommendation</h4><!-- end field 61ee7d68-9c1a-438f-af9d-48acf12bded5 -->","summary":null,"htmlStringContent":"<!-- begin item c9e9112e-2672-4fe5-a608-35be59c82f48 --><!-- begin field a2516026-7db7-42ba-b33c-b62e49f740c5 --><p>The recommendations on contraindications for polio vaccination are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 26: Poliomyelitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013b</a>] and <em>Chapter 6: Contraindications and special considerations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2017a</a>].</p><h5>Continuing vaccination in children with previous reactions</h5><ul><li>The recommendation to continue vaccination in children with previous systemic and local reactions is based on Canadian data suggesting that further doses were not associated with recurrence or worsening of the preceding events [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013b</a>].</li></ul><!-- end field a2516026-7db7-42ba-b33c-b62e49f740c5 --><!-- end item c9e9112e-2672-4fe5-a608-35be59c82f48 -->","subChapters":[]}]},{"id":"209ba013-d0cb-5cc6-9650-e85e76c39a05","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 5493b2cf-3091-4a8f-8cb5-b6e645b65d72 --><h3>Adverse effects</h3><!-- end field 5493b2cf-3091-4a8f-8cb5-b6e645b65d72 -->","summary":null,"htmlStringContent":"<!-- begin item 906fe8a2-fa73-48bd-a725-1e511712d756 --><!-- begin field e9bec62a-d0d8-48a2-8404-b9287fb6188b --><ul><li>Pain, swelling, or redness at the injection site are common and may occur more frequently following subsequent doses. A small, painless nodule may form at the injection site; this usually disappears and is of no consequence.</li><li>Confirmed anaphylaxis occurs extremely rarely. Data from the UK, Canada, and the USA point to rates of 0.65–3 anaphylaxis events per million doses of vaccine given.</li></ul><!-- end field e9bec62a-d0d8-48a2-8404-b9287fb6188b --><!-- end item 906fe8a2-fa73-48bd-a725-1e511712d756 -->","subChapters":[{"id":"6bc6df80-d3da-5c4c-861a-975b59e1cb9e","slug":"basis-for-recommendation-391","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 49d93c78-fb7f-4835-9719-026589169166 --><h4>Basis for recommendation</h4><!-- end field 49d93c78-fb7f-4835-9719-026589169166 -->","summary":null,"htmlStringContent":"<!-- begin item 391ce2a0-5ddf-4462-9827-9e939201218e --><!-- begin field f36391d1-103a-49f3-bc62-81cd01c2ff81 --><p>The information on adverse effects of polio vaccination is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 26: Poliomyelitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013b</a>].</p><!-- end field f36391d1-103a-49f3-bc62-81cd01c2ff81 --><!-- end item 391ce2a0-5ddf-4462-9827-9e939201218e -->","subChapters":[]}]},{"id":"89ddbf01-d34b-5fdd-8c54-989068ca5752","slug":"how-to-administer-polio-containing-vaccines","fullItemName":"How to administer polio-containing vaccines","depth":3,"htmlHeader":"<!-- begin field a3e50324-9dd7-4167-a289-c3f139ec2f8d --><h3>How to administer polio-containing vaccines</h3><!-- end field a3e50324-9dd7-4167-a289-c3f139ec2f8d -->","summary":null,"htmlStringContent":"<!-- begin item 5f5e061c-e4a1-4559-ae97-e59f21a2d4ec --><!-- begin field 27a84e8d-2925-4278-9f58-82a89b1590e5 --><ul><li><strong>Obtain written or verbal consent at the time of vaccination for people aged over 16 years.</strong><strong> For younger people it is usual to get consent from a person with parental responsibility.</strong><ul><li>Adults over 18 years of age are presumed to be competent to consent to treatment provided they can comprehend and retain the information they are given, and they can consider the facts and make an informed decision.</li></ul></li><li><strong>Ensure that:</strong> <ul><li>There are no <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/poliomyelitis/#contraindications-to-vaccine\">contraindications</a> to the vaccine.</li><li>The person, parent, or carer has been fully informed about the vaccine and the vaccination procedure.</li><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/poliomyelitis/#adverse-effects\">adverse reactions</a> have been discussed and the person, parent, or carer is aware of how to manage them. </li><li>The vaccine is correct, has been stored appropriately, and has not expired. </li></ul><ul><li>The vaccination site has been washed with soap and water if it is visibly dirty. </li></ul></li><li><strong>Polio-containing vaccine is usually given by intramuscular (IM) injection,</strong> into the upper arm in children and adults, or the anterolateral thigh in infants under 1 year of age. However, if the person has a bleeding disorder, the vaccine should be given by deep subcutaneous (SC) injection to reduce the risk of bleeding. </li><li><strong>Polio-containing vaccine can be given at the same time as other vaccines.</strong> If an additional vaccine is required on the same day, use separate limbs if possible, or inject at sites at least 2.5 cm apart. </li><li><strong>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine.</strong> </li><li><strong>Observe the person after vaccination to detect immediate adverse reactions.</strong> Ensure any bleeding has stopped and check for any symptoms of anaphylaxis before they leave.<ul><li>Anaphylaxis is extremely rare, and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field 27a84e8d-2925-4278-9f58-82a89b1590e5 --><!-- end item 5f5e061c-e4a1-4559-ae97-e59f21a2d4ec -->","subChapters":[{"id":"21c5215b-07af-5a70-8cfc-602e2f32718b","slug":"basis-for-recommendation-028","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e71acf72-9467-4c53-8d22-78b6e0a14fec --><h4>Basis for recommendation</h4><!-- end field e71acf72-9467-4c53-8d22-78b6e0a14fec -->","summary":null,"htmlStringContent":"<!-- begin item 02846e5b-ee0b-411b-96b9-83bfa0ca27b3 --><!-- begin field a6d0826b-1651-46d5-ab63-038ed3ce9196 --><p>The recommendations on administering polio-containing vaccines are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease</em> <em>(The Green Book) Chapter 26: Poliomyelitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013b</a>], <em>Chapter 2: Consent </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>], <em>Chapter 4: Immunisation procedures</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>], and <em>Chapter 8: Vaccine safety and adverse effects</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013g</a>], and are also pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Obtaining consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>].</li></ul><h5>Site of administration</h5><div><ul><li>In people over the age of 1 year, vaccines are routinely given into the deltoid muscle as it is convenient, providing easy access, and it reduces the risk of localized reactions, which are common when vaccines are given subcutaneously.</li><li>The gluteal muscle should be avoided. The needle may not penetrate through adipose tissue into the muscle, and this may cause a poor immunological response to the vaccine. In addition, there is a risk of damage to underlying structures such as the sciatic nerve [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>].</li></ul></div><!-- end field a6d0826b-1651-46d5-ab63-038ed3ce9196 --><!-- end item 02846e5b-ee0b-411b-96b9-83bfa0ca27b3 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}